MY142195A - Controlled-release compositions - Google Patents

Controlled-release compositions

Info

Publication number
MY142195A
MY142195A MYPI20034063A MY142195A MY 142195 A MY142195 A MY 142195A MY PI20034063 A MYPI20034063 A MY PI20034063A MY 142195 A MY142195 A MY 142195A
Authority
MY
Malaysia
Prior art keywords
controlled
release
matrix
agent
release compositions
Prior art date
Application number
Other languages
English (en)
Inventor
Lenaerts Vincent
Ouadji-Nkiki Patricia Laure
Bacon Jonathan
Ouzerourou Rachid
Gervais Sonia
Rahmouni Miloud
Smith Damon
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of MY142195A publication Critical patent/MY142195A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI20034063 2002-10-25 2003-10-25 Controlled-release compositions MY142195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28102602A 2002-10-25 2002-10-25
US51000003P 2003-10-10 2003-10-10

Publications (1)

Publication Number Publication Date
MY142195A true MY142195A (en) 2010-10-15

Family

ID=44539364

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20034063 MY142195A (en) 2002-10-25 2003-10-25 Controlled-release compositions

Country Status (3)

Country Link
JP (1) JP4897930B2 (https=)
IL (1) IL168113A (https=)
MY (1) MY142195A (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Also Published As

Publication number Publication date
JP2011153154A (ja) 2011-08-11
JP4897930B2 (ja) 2012-03-14
IL168113A (en) 2013-04-30

Similar Documents

Publication Publication Date Title
PT1558935E (pt) Composições de libertação controlada
ES2101082T3 (es) Composiciones de liberacion controlada.
NZ515359A (en) Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
NL2000281A1 (nl) Vaste farmaceutische samenstellingen die pregabaline bevatten.
HK1051487A1 (zh) 含有阿片样激动剂和拮抗剂的控释组合物
TWI235068B (en) Sustained-release pharmaceutical composition
MX9707585A (es) Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
ZA200509477B (en) Delayed release tablet with defined core geometry
CA2457361A1 (en) Opioid agonist formulations with releasable and sequestered antagonist
HRP20050625A2 (hr) Tablete bupropion hidroklorida s promijenjenim otpuštanjem
AR001405A1 (es) Formulación oral de 2-metil-tieno-beno-diacepina.
ATE268593T1 (de) Bupropionhydrochlorid enthaltende tabletten mit gesteuerter wirkstoffabgabe
AU7148101A (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
CY2460B1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors.
WO2004064815A8 (en) Oral dosage formulation
PL2057984T3 (pl) Tabletki z hydromorfonem o przedłużonym uwalnianiu
AU2963400A (en) Improved controlled release compositions and method
ES2196620T3 (es) Formulacion de liberacion prolongada que contiene venlafaxina.
AU2002233271A1 (en) Substitued oxazoles and thiazoles as hppar alpha agonists
DE69512638D1 (de) Schnell auflösende orale darreichungsform
WO2004022002A3 (en) Combined immediate release and extended release analgesic composition
MY142195A (en) Controlled-release compositions
UA86929C2 (ru) Композиция с контролируемым высвобождением
WO2003034822A3 (de) Pulverförmige wirkstoff-formulierungen
WO2007025182A3 (en) Drug compositions containing controlled release hypromellose matrices